These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8249053)

  • 41. Determination of the angiotensin converting enzyme inhibitor benazeprilat in plasma and urine by an enzymic method.
    Graf P; Frueh F; Schmid K
    J Chromatogr; 1988 Mar; 425(2):353-61. PubMed ID: 2836452
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Determination of angiotensin converting enzyme inhibitory activity by high-performance liquid chromatography/electrospray-mass spectrometry.
    Xiao X; Luo X; Chen B; Yao S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Apr; 834(1-2):48-54. PubMed ID: 16513436
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development and validation of liquid chromatography-tandem mass spectrometric method for simultaneous determination of fosinopril and its active metabolite fosinoprilat in human plasma.
    Cui S; Feng F; Ma M; Liu H; Chen Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jul; 854(1-2):143-51. PubMed ID: 17482898
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of a fast liquid chromatography/mass spectrometry screening method for angiotensin-converting enzyme (ACE) inhibitors in complex natural mixtures like snake venom.
    Siemerink M; Schebb NH; Liesener A; Perchuc AM; Schöni R; Wilmer M; Hayen H; Karst U; Vogel M
    Rapid Commun Mass Spectrom; 2010 Mar; 24(5):687-97. PubMed ID: 20162537
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetic and pharmacodynamic properties of ramipril in patients with congestive heart failure (NYHA III-IV).
    Gerckens U; Grube E; Mengden T; Sigel H; Wagner WL; Lahn T; Irmisch R; Metzger H
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S49-51. PubMed ID: 2474102
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A radioimmunoassay for MC-838 (altiopril calcium), a novel angiotensin-converting enzyme inhibitor.
    Hinohara Y; Tanaka S; Wakabayashi K
    J Pharmacobiodyn; 1988 Jun; 11(6):411-5. PubMed ID: 3171883
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enzyme immunoassay for nomegestrol acetate in human plasma.
    Ezan E; Benech H; Bucourt R; Ardouin T; Tchernatinsky C; Thomas JL; Paris J; Grognet JM
    J Steroid Biochem Mol Biol; 1993 Oct; 46(4):507-14. PubMed ID: 8217881
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assay of zofenopril and its active metabolite zofenoprilat by liquid chromatography coupled with tandem mass spectrometry.
    Dal Bo L; Mazzucchelli P; Marzo A
    J Chromatogr B Biomed Sci Appl; 2000 Dec; 749(2):287-94. PubMed ID: 11145066
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An enzyme immunoassay for rat prolactin: application to the determination of plasma levels.
    Duhau L; Grassi J; Grouselle D; Enjalbert A; Grognet JM
    J Immunoassay; 1991; 12(2):233-50. PubMed ID: 2045480
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Direct determination of angiotensin-converting enzyme inhibitors in plasma by radioenzymatic assay.
    Reydel-Bax P; Redalieu E; Rakhit A
    Clin Chem; 1987 Apr; 33(4):549-53. PubMed ID: 3030582
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical analysis of sampatrilat, a combined renal endopeptidase and angiotensin-converting enzyme inhibitor I: assay in plasma of human volunteers by atmospheric-pressure ionisation mass-spectrometry following derivatisation with BF3-methanol.
    Venn RF; Kaye B; Macrae PV; Saunders KC
    J Pharm Biomed Anal; 1998 Jan; 16(5):875-81. PubMed ID: 9535199
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A dose-response study of HOE 498, a new non-sulphydryl converting enzyme inhibitor, on blood pressure, pulse rate and the renin-angiotensin-aldosterone system in normal man.
    Manhem PJ; Ball SG; Morton JJ; Murray GD; Leckie BJ; Fraser R; Robertson JI
    Br J Clin Pharmacol; 1985 Jul; 20(1):27-35. PubMed ID: 2992562
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hydrophilic interaction liquid chromatography/positive ion electrospray ionization mass spectrometry method for the quantification of perindopril and its main metabolite in human plasma.
    Georgakakou S; Kazanis M; Panderi I
    Anal Bioanal Chem; 2010 Jul; 397(6):2161-70. PubMed ID: 20195579
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Time-resolved fluoroimmunoassay for the determination of lisinopril and enalaprilat in human serum.
    Yuan AS; Gilbert JD
    J Pharm Biomed Anal; 1996 May; 14(7):773-81. PubMed ID: 8809701
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Simultaneous determination of benazepril hydrochloride and benazeprilat in plasma by high-performance liquid chromatography/electrospray-mass spectrometry.
    Xiao W; Chen B; Yao S; Cheng Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jan; 814(2):303-8. PubMed ID: 15639452
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quantitative determination of the angiotensin-converting enzyme inhibitor lisinopril in human plasma by stable isotope dilution gas chromatography/negative ion chemical ionization mass spectrometry.
    Leis HJ; Fauler G; Raspotnig G; Windischhofer W
    Rapid Commun Mass Spectrom; 1998; 12(21):1591-4. PubMed ID: 9807834
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Physicochemical and enzyme binding kinetic properties of a new angiotensin-converting enzyme inhibitor ramipril and their clinical implications.
    Bender N; Rangoonwala B; Rosenthal J; Vasmant D
    Clin Physiol Biochem; 1990; 8 Suppl 1():44-52. PubMed ID: 2147879
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacological and toxicological studies of the new angiotensin converting enzyme inhibitor moexipril hydrochloride.
    Friehe H; Ney P
    Arzneimittelforschung; 1997 Feb; 47(2):132-44. PubMed ID: 9079232
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Humoral and blood pressure effects of the angiotensin converting enzyme inhibitor ramipril in essential hypertension.
    Lenz T; Distler A; Haller H; Meyer-Sabellek W; Wilp C; Tansey MJ; Eckert HG; Metzger H; Irmisch R; Philipp T
    Arzneimittelforschung; 1986 Nov; 36(11):1693-6. PubMed ID: 3028438
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The pharmacokinetics of perindopril in patients with liver cirrhosis.
    Thiollet M; Funck-Brentano C; Grangé JD; Midavaine M; Resplandy G; Jaillon P
    Br J Clin Pharmacol; 1992 Mar; 33(3):326-8. PubMed ID: 1576057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.